Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-006)

Sirion Therapeutics, Inc.

Overview

The purpose of this phase III, open-label study is to determine the safety and tolerability of cyclosporine in the treatment of dry eye syndrome.

Study Type

INTERVENTIONAL

Allocation

Masking

NONE

Conditions

Dry Eye Syndromes

Interventions

cyclosporine ADRUG

Eligibility

Sex: ALLMin age: 2 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Diagnosis of dry eye syndrome Exclusion Criteria: * Intraocular or refractive surgery in the study eye within 3 months prior to study start * Unwilling to discontinue use of contact lenses during the study * Pregnancy or lactation

Locations (1)

Clayton Eye Center

Morrow, Georgia, United States

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.